Correspondence

COVID-19: Convalescent plasma as a potential therapy

Bookmark and Share
K van den Berg, M Vermeulen, T N Glatt, S Wasserman, C L Barrett, J Peter, D Brittain, V J Louw

Abstract


-

Authors' affiliations

K van den Berg, Translational Research, Medical Division, South African National Blood Service, Roodepoort, South Africa; Division of Clinical Haematology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa

M Vermeulen, Operations Testing, Operations Division, South African National Blood Service, Roodepoort, South Africa

T N Glatt, Cellular Therapy Laboratory, South African National Blood Service, Roodepoort, South Africa

S Wasserman, Division of Infectious Diseases and HIV Medicine, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa; Wellcome Centre for Infectious Diseases Research in Africa, Institute of Infectious Disease and Molecular Medicine, Faculty of Health Sciences, University of Cape Town, South Africa

C L Barrett, School of Clinical Medicine, Faculty of Health Sciences, University of the Free State, Bloemfontein, South Africa

J Peter, Division of Allergy and Clinical Immunology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa; Allergy and Immunology Unit, University of Cape Town Lung Institute, South Africa

D Brittain, Alberts Cellular Therapy, Netcare Pretoria East Hospital, South Africa

V J Louw, Division of Clinical Haematology, Department of Medicine, Faculty of Health Sciences, University of Cape Town, South Africa

Full Text

PDF (94KB)

Cite this article

South African Medical Journal 2020;110(7):562-563. DOI:10.7196/SAMJ.2020.v110i7.14983

Article History

Date submitted: 2020-06-04
Date published: 2020-06-04

Article Views

Abstract views: 3417
Full text views: 577

Comments on this article

*Read our policy for posting comments here